PRGO
59
-5
ADI
62
-3
KEY
33
-4
ORCL
58
-2
KMX
46
-2
GWW
53
-5
GE
68
-3
COF
65
-2
UNM
66
-2
RL
69
-4
RSG
73
-4
MAR
56
-3
SYY
56
-8
CNX
61
-8
SNA
53
-5
PLD
43
-5
WHR
35
-4
KSS
28
-4
SE
50
-7
GLW
68
7
PRGO
59
-5
ADI
62
-3
KEY
33
-4
ORCL
58
-2
KMX
46
-2
GWW
53
-5
GE
68
-3
COF
65
-2
UNM
66
-2
RL
69
-4
RSG
73
-4
MAR
56
-3
SYY
56
-8
CNX
61
-8
SNA
53
-5
PLD
43
-5
WHR
35
-4
KSS
28
-4
SE
50
-7
GLW
68
7
Financhill
Back

IGM Biosciences 10K Form

Buy
58

IGMS
IGM Biosciences

Last Price:
9.47
Seasonality Move:
-4.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGMS News And Ratings

See the #1 stock for the next 7 days that we like better than IGMS

IGMS Financial Statistics

Sales & Book Value

Annual Sales: $2.13M
Cash Flow: $-49.46M
Price / Cash Flow: 0
Annual Sales: $3.46
Price / Book: 2.78

Profitability

EPS (TTM): -4.78000
Net Income (TTM): $-246.42M
Gross Margin: --
Return on Equity: -99.17%
Return on Assets: -52.33%

IGM Biosciences Earnings Forecast

Key IGM Biosciences Financial Ratios

  • The Research & Development expenses have been 10,118.26% of Revenue.
  • The Net Earning history of IGMS is -11,568.83% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

IGM Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IGMS
CUSIP: 449585
Website: igmbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.18
Quick Ratio: 7.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGMS Technical Analysis vs Fundamental Analysis

Buy
58
IGM Biosciences (IGMS) is a Buy

Is IGM Biosciences a Buy or a Sell?

  • IGM Biosciences stock is rated a Buy
    The current IGM Biosciences [IGMS] share price is $9.61. The Score for IGMS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.